-
1
-
-
84897416706
-
-
World Health Organization December 2011 [consultado 18 Sep 2012]. Disponible en
-
World Health Organization. Meningococcal meningitis factsheet. December 2011 [consultado 18 Sep 2012]. Disponible en: http://www.who.int/mediacentre/ factsheets/fs141/en/index.html
-
Meningococcal Meningitis Factsheet
-
-
-
2
-
-
67349267346
-
Global epidemiology of meningococcal disease
-
L.H. Harrison, C.L. Trotter, and M.E. Ramsay Global epidemiology of meningococcal disease Vaccine 27 Suppl 2 2009 B51 B63
-
(2009)
Vaccine
, vol.27
, Issue.SUPPL. 2
-
-
Harrison, L.H.1
Trotter, C.L.2
Ramsay, M.E.3
-
3
-
-
0035799462
-
Meningococcal disease
-
N.E. Rosenstein, B.A. Perkins, D.S. Stephens, T. Popovic, and J.M. Hughes Meningococcal disease N Engl J Med 344 2001 1378 1388
-
(2001)
N Engl J Med
, vol.344
, pp. 1378-1388
-
-
Rosenstein, N.E.1
Perkins, B.A.2
Stephens, D.S.3
Popovic, T.4
Hughes, J.M.5
-
4
-
-
84861117523
-
The changing and dynamic epidemiology of meningococcal disease
-
S.A. Halperin, J.A. Bettinger, B. Greenwood, L.H. Harrison, J. Jelfs, and S.N. Ladhani et al. The changing and dynamic epidemiology of meningococcal disease Vaccine 30 Suppl 2 2011 B26 B36
-
(2011)
Vaccine
, vol.30
, Issue.SUPPL. 2
-
-
Halperin, S.A.1
Bettinger, J.A.2
Greenwood, B.3
Harrison, L.H.4
Jelfs, J.5
Ladhani, S.N.6
-
6
-
-
77956936981
-
Meningococcal disease: The organism, clinical presentation, and worldwide epidemiology
-
J.A. Al-Tawfiq, T.A. Clark, and Z.A. Memish Meningococcal disease: The organism, clinical presentation, and worldwide epidemiology J Travel Med 17 Suppl 2010 3 8
-
(2010)
J Travel Med
, vol.17
, Issue.SUPPL.
, pp. 3-8
-
-
Al-Tawfiq, J.A.1
Clark, T.A.2
Memish, Z.A.3
-
7
-
-
77951429827
-
Advances in the development of vaccines against Neisseria meningitidis
-
L.K. Tan, G.M. Carlone, and R. Borrow Advances in the development of vaccines against Neisseria meningitidis N Engl J Med 362 2010 1511 1520
-
(2010)
N Engl J Med
, vol.362
, pp. 1511-1520
-
-
Tan, L.K.1
Carlone, G.M.2
Borrow, R.3
-
8
-
-
84856379848
-
Meningococcal vaccines: WHO position paper, November 2011
-
World Health Organization Disponible en
-
World Health Organization Meningococcal vaccines: WHO position paper, November 2011 Weekly epidemiological record. 47 2011 521 540 Disponible en: http://www.who.int/wer/2011/wer8647.pdf
-
(2011)
Weekly Epidemiological Record.
, vol.47
, pp. 521-540
-
-
-
9
-
-
84897377178
-
-
European Centre for Disease Prevention and Control Surveillance reports [consultado Nov 2012]. Disponible en
-
European Centre for Disease Prevention and Control. Surveillance of invasive bacterial diseases in Europe 2008/2009. Surveillance reports [consultado Nov 2012]. Disponible en: http://www.ecdc.europa.eu/en/publications/ Publications/1107-SUR-IBD-2008-09.pdf
-
(2009)
Surveillance of Invasive Bacterial Diseases in Europe 2008
-
-
-
10
-
-
84897453246
-
-
Ministerio de Salud. Gobierno de Chile. Comenzó vacunación preventiva contra la meningitis en Peñalolén. [consultado Nov 2012]. Disponible en
-
Ministerio de Salud. Gobierno de Chile. Comenzó vacunación preventiva contra la meningitis en Peñalolén. [consultado Nov 2012]. Disponible en: http://www.minsal.gob.cl/portal/url/page/minsalcl/g- noticias/g-visualizacion/noticias-destacadas-6360714.html
-
-
-
-
12
-
-
84892566297
-
Centro Nacional de Epidemiología. Instituto Carlos III. Comentario epidemiológico de las enfermedades de declaración obligatoria y sistema de información microbiológica. España. Año 2010
-
Servicio de Vigilancia Epidemiológica
-
Servicio de Vigilancia Epidemiológica Centro Nacional de Epidemiología. Instituto Carlos III. Comentario epidemiológico de las enfermedades de declaración obligatoria y sistema de información microbiológica. España. Año 2010 Boletín Epidemiológico Semanal 19 2011 100 116
-
(2011)
Boletín Epidemiológico Semanal
, vol.19
, pp. 100-116
-
-
-
13
-
-
79956208618
-
Enfermedad meningocócica en España. Análisis de la temporada 2006-2007
-
R. Cano, and M. Garrido Enfermedad meningocócica en España. Análisis de la temporada 2006-2007 Boletín Epidemiológico Semanal 16 2008 73 84
-
(2008)
Boletín Epidemiológico Semanal
, vol.16
, pp. 73-84
-
-
Cano, R.1
Garrido, M.2
-
14
-
-
79960564516
-
The burden of hospitalizations for meningococcal infection in Spain (1997-2008)
-
R. Gil-Prieto, L. Garcia-Garcia, A. Alvaro-Meca, A. Gonzalez-Escalada, P. Viguera Ester, and A. Gil De Miguel The burden of hospitalizations for meningococcal infection in Spain (1997-2008) Vaccine 29 2011 5765 5770
-
(2011)
Vaccine
, vol.29
, pp. 5765-5770
-
-
Gil-Prieto, R.1
Garcia-Garcia, L.2
Alvaro-Meca, A.3
Gonzalez-Escalada, A.4
Viguera Ester, P.5
Gil De Miguel, A.6
-
16
-
-
68949175293
-
Neisseria meningitidis: Epidemiology, treatment and prevention in adolescents
-
K.S. Brigham, and T.J. Sandora Neisseria meningitidis: Epidemiology, treatment and prevention in adolescents Curr Opin Pediatr 21 2009 437 443
-
(2009)
Curr Opin Pediatr
, vol.21
, pp. 437-443
-
-
Brigham, K.S.1
Sandora, T.J.2
-
17
-
-
77954616695
-
Management of bacterial meningitis and meningococcal septicaemia in children and young people: Summary of NICE guidance
-
C. Visintin, M.A. Mugglestone, E.J. Fields, P. Jacklin, M.S. Murphy, and A.J. Pollard Management of bacterial meningitis and meningococcal septicaemia in children and young people: Summary of NICE guidance BMJ 340 2010 c3209
-
(2010)
BMJ
, vol.340
, pp. 3209
-
-
Visintin, C.1
Mugglestone, M.A.2
Fields, E.J.3
Jacklin, P.4
Murphy, M.S.5
Pollard, A.J.6
-
18
-
-
77951910339
-
Global and regional risk of disabling sequelae from bacterial meningitis: A systematic review and meta-analysis
-
K. Edmond, A. Clark, V.S. Korczak, C. Sanderson, U.K. Griffiths, and I. Rudan Global and regional risk of disabling sequelae from bacterial meningitis: A systematic review and meta-analysis Lancet Infect Dis 10 2010 317 328
-
(2010)
Lancet Infect Dis
, vol.10
, pp. 317-328
-
-
Edmond, K.1
Clark, A.2
Korczak, V.S.3
Sanderson, C.4
Griffiths, U.K.5
Rudan, I.6
-
19
-
-
84865145319
-
Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): A case-control study
-
R.M. Viner, R. Booy, H. Johnson, W.J. Edmunds, L. Hudson, and H. Bedford et al. Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): A case-control study Lancet Neurol 11 2012 774 783
-
(2012)
Lancet Neurol
, vol.11
, pp. 774-783
-
-
Viner, R.M.1
Booy, R.2
Johnson, H.3
Edmunds, W.J.4
Hudson, L.5
Bedford, H.6
-
21
-
-
84883963562
-
-
Department of Health, Victoria, Australia Epidemiology and surveillance [consultado Feb 2012]. Disponible en: ideas.health.vic.gov.au/bluebook/ meningococcal.asp
-
Department of Health, Victoria, Australia. Infectious diseases. Epidemiology and surveillance [consultado Feb 2012]. Disponible en: ideas.health.vic.gov.au/bluebook/meningococcal.asp
-
Infectious Diseases
-
-
-
22
-
-
67349185861
-
Meningococcal carriage and disease -population biology and evolution
-
D.A. Caugant, and M.C. Maiden Meningococcal carriage and disease -population biology and evolution Vaccine 27 Suppl 2 2009 B64 B70
-
(2009)
Vaccine
, vol.27
, Issue.SUPPL. 2
-
-
Caugant, D.A.1
Maiden, M.C.2
-
23
-
-
0037238233
-
Impact of meningococcal vaccination with combined serogroups A and C polysaccharide vaccine on carriage of Neisseria meningitidis C
-
S. Fernandez, L. Arreaza, I. Santiago, A. Malvar, S. Berron, and J.A. Vazquez et al. Impact of meningococcal vaccination with combined serogroups A and C polysaccharide vaccine on carriage of Neisseria meningitidis C J Med Microbiol 52 2003 75 77
-
(2003)
J Med Microbiol
, vol.52
, pp. 75-77
-
-
Fernandez, S.1
Arreaza, L.2
Santiago, I.3
Malvar, A.4
Berron, S.5
Vazquez, J.A.6
-
24
-
-
17044431681
-
Genetic analysis of meningococci carried by children and young adults
-
H. Claus, M.C. Maiden, D.J. Wilson, N.D. McCarthy, K.A. Jolley, and R. Urwin et al. Genetic analysis of meningococci carried by children and young adults J Infect Dis 191 2005 1263 1271
-
(2005)
J Infect Dis
, vol.191
, pp. 1263-1271
-
-
Claus, H.1
Maiden, M.C.2
Wilson, D.J.3
McCarthy, N.D.4
Jolley, K.A.5
Urwin, R.6
-
25
-
-
0023607404
-
The Stonehouse survey: Nasopharyngeal carriage of meningococci and Neisseria lactamica
-
K.A. Cartwright, J.M. Stuart, D.M. Jones, and N.D. Noah The Stonehouse survey: Nasopharyngeal carriage of meningococci and Neisseria lactamica Epidemiol Infect 99 1987 591 601
-
(1987)
Epidemiol Infect
, vol.99
, pp. 591-601
-
-
Cartwright, K.A.1
Stuart, J.M.2
Jones, D.M.3
Noah, N.D.4
-
26
-
-
0027954586
-
Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population
-
D.A. Caugant, E.A. Hoiby, P. Magnus, O. Scheel, T. Hoel, and G. Bjune et al. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population J Clin Microbiol 32 1994 323 330
-
(1994)
J Clin Microbiol
, vol.32
, pp. 323-330
-
-
Caugant, D.A.1
Hoiby, E.A.2
Magnus, P.3
Scheel, O.4
Hoel, T.5
Bjune, G.6
-
27
-
-
33744908866
-
Social behavior and meningococcal carriage in British teenagers
-
J. MacLennan, G. Kafatos, K. Neal, N. Andrews, J.C. Cameron, and R. Roberts et al. Social behavior and meningococcal carriage in British teenagers Emerg Infect Dis 12 2006 950 957
-
(2006)
Emerg Infect Dis
, vol.12
, pp. 950-957
-
-
Maclennan, J.1
Kafatos, G.2
Neal, K.3
Andrews, N.4
Cameron, J.C.5
Roberts, R.6
-
28
-
-
84857569275
-
The systemic inflammatory response syndrome (SIRS), sepsis, and septic shock
-
S.S. Long, L.K. Pickering, C.G. Prober, 3 rd ed. Churchill Livingstone Philadelphia
-
J. Guzman-Cottrill, S. Nadel, and B. Goldstein The systemic inflammatory response syndrome (SIRS), sepsis, and septic shock S.S. Long, L.K. Pickering, C.G. Prober, Principles and practice of pediatric infectious diseases 3 rd ed. 2008 Churchill Livingstone Philadelphia 99 110
-
(2008)
Principles and Practice of Pediatric Infectious Diseases
, pp. 99-110
-
-
Guzman-Cottrill, J.1
Nadel, S.2
Goldstein, B.3
-
29
-
-
84897392218
-
Neisseria meningitidis
-
S.S. Long, L.K. Pickering, C.G. Prober, 3 rd ed. Churchill Livingstone Elsevier Philadelphia
-
A. Pollard, and A. Finn Neisseria meningitidis S.S. Long, L.K. Pickering, C.G. Prober, Principles and practice of pediatric infectious diseases 3 rd ed. 2008 Churchill Livingstone Elsevier Philadelphia 99 110
-
(2008)
Principles and Practice of Pediatric Infectious Diseases
, pp. 99-110
-
-
Pollard, A.1
Finn, A.2
-
30
-
-
77649191024
-
Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: A systematic review
-
A. Van den Bruel, T. Haj-Hassan, M. Thompson, F. Buntinx, and D. Mant Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review Lancet 375 2010 834 845
-
(2010)
Lancet
, vol.375
, pp. 834-845
-
-
Van Den Bruel, A.1
Haj-Hassan, T.2
Thompson, M.3
Buntinx, F.4
Mant, D.5
-
31
-
-
0033957876
-
Update on meningococcal disease with emphasis on pathogenesis and clinical management
-
M. Van Deuren, P. Brandtzaeg, and J.W. van der Meer Update on meningococcal disease with emphasis on pathogenesis and clinical management Clin Microbiol Rev 13 2000 144 166
-
(2000)
Clin Microbiol Rev
, vol.13
, pp. 144-166
-
-
Van Deuren, M.1
Brandtzaeg, P.2
Van Der Meer, J.W.3
-
32
-
-
84897416706
-
-
World Health Organization December 2010 [consultado 23 Oct 2010]. Disponible en
-
World Health Organization. Meningococcal meningitis factsheet. December 2010 [consultado 23 Oct 2010]. Disponible en: http://www.who.int/mediacentre/ factsheets/fs141/en/index.html
-
Meningococcal Meningitis Factsheet
-
-
-
34
-
-
79958035895
-
Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles
-
X. Bai, J. Findlow, and R. Borrow Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles Expert Opin Biol Ther 11 2011 969 985
-
(2011)
Expert Opin Biol Ther
, vol.11
, pp. 969-985
-
-
Bai, X.1
Findlow, J.2
Borrow, R.3
-
35
-
-
79954802756
-
The Global Meningococcal Initiative: Recommendations for reducing the global burden of meningococcal disease
-
L.H. Harrison, S.I. Pelton, A. Wilder-Smith, J. Holst, M.A. Safadi, and J.A. Vazquez et al. The Global Meningococcal Initiative: Recommendations for reducing the global burden of meningococcal disease Vaccine 29 2011 3363 3371
-
(2011)
Vaccine
, vol.29
, pp. 3363-3371
-
-
Harrison, L.H.1
Pelton, S.I.2
Wilder-Smith, A.3
Holst, J.4
Safadi, M.A.5
Vazquez, J.A.6
-
36
-
-
81355149563
-
Epidemiology and prevention of meningococcal disease: A critical appraisal of vaccine policies
-
M.A. Safadi, and E.D. McIntosh Epidemiology and prevention of meningococcal disease: A critical appraisal of vaccine policies Expert Rev Vaccines. 10 2011 1717 1730
-
(2011)
Expert Rev Vaccines.
, vol.10
, pp. 1717-1730
-
-
Safadi, M.A.1
McIntosh, E.D.2
-
37
-
-
85046979879
-
Meningococcal disease: The advances and challenges of meningococcal disease prevention
-
R. Yogev, and T. Tan Meningococcal disease: The advances and challenges of meningococcal disease prevention Hum Vaccin 7 2011 828 837
-
(2011)
Hum Vaccin
, vol.7
, pp. 828-837
-
-
Yogev, R.1
Tan, T.2
-
38
-
-
80053960664
-
Changing epidemiology of meningococcal disease in Europe from the mid-20th to the early 21st Century
-
P. Kriz, H. Wieffer, K. Holl, M. Rosenlund, S. Budhia, and A. Vyse Changing epidemiology of meningococcal disease in Europe from the mid-20th to the early 21st Century Expert Rev Vaccines 10 2011 1477 1486
-
(2011)
Expert Rev Vaccines
, vol.10
, pp. 1477-1486
-
-
Kriz, P.1
Wieffer, H.2
Holl, K.3
Rosenlund, M.4
Budhia, S.5
Vyse, A.6
-
39
-
-
33644840604
-
Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands
-
S.C. De Greeff, H.E. de Melker, L. Spanjaard, L.M. Schouls, and A. van Derende Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands Pediatr Infect Dis J 25 2006 79 80
-
(2006)
Pediatr Infect Dis J
, vol.25
, pp. 79-80
-
-
De Greeff, S.C.1
De Melker, H.E.2
Spanjaard, L.3
Schouls, L.M.4
Van Derende, A.5
-
40
-
-
20444437173
-
Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain
-
A. Larrauri, R. Cano, M. Garcia, and S. Mateo Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain Vaccine 23 2005 4097 4100
-
(2005)
Vaccine
, vol.23
, pp. 4097-4100
-
-
Larrauri, A.1
Cano, R.2
Garcia, M.3
Mateo, S.4
-
41
-
-
84897442959
-
Grupo de trabajo de enfermedad meningocócica de la ponencia de programa y registro de vacunación
-
Modificación de la pauta de vacunación frente meningitis C. Ministerio de Sanidad y Consumo
-
Grupo de trabajo de enfermedad meningocócica de la ponencia de programa y registro de vacunación. Situación actual de la enfermedad meningocócica en España. Modificación de la pauta de vacunación frente meningitis C. Ministerio de Sanidad y Consumo, 2005.
-
(2005)
Situación Actual de la Enfermedad Meningocócica en España
-
-
-
42
-
-
79956208618
-
Centro Nacional de Epidemiología, Instituto de Salud Carlos III. Enfermedad meningocócica en España. Análisis de la temporada 2006-2007
-
R. Cano, and M. Garrido Centro Nacional de Epidemiología, Instituto de Salud Carlos III. Enfermedad meningocócica en España. Análisis de la temporada 2006-2007 Bol Epidemiol Sem 16 2008 73 76
-
(2008)
Bol Epidemiol Sem
, vol.16
, pp. 73-76
-
-
Cano, R.1
Garrido, M.2
-
43
-
-
84856726207
-
Microbiology and public health: New challenges in surveillance and control of meningococcal disease
-
R. Abad, and J.A. Vazquez Microbiology and public health: new challenges in surveillance and control of meningococcal disease Enferm Infecc Microbiol Clin 30 2012 53 55
-
(2012)
Enferm Infecc Microbiol Clin
, vol.30
, pp. 53-55
-
-
Abad, R.1
Vazquez, J.A.2
-
44
-
-
80053490173
-
Universal protein vaccines against Neisseria meningitidis serogroup B, Streptococcus pneumoniae and influenza
-
N. Principi, and S. Esposito Universal protein vaccines against Neisseria meningitidis serogroup B, Streptococcus pneumoniae and influenza Hum Vaccin 7 2011 905 912
-
(2011)
Hum Vaccin
, vol.7
, pp. 905-912
-
-
Principi, N.1
Esposito, S.2
-
45
-
-
3042678850
-
Antigenic and/or phase variation of PorA protein in non-subtypable Neisseria meningitidis strains isolated in Spain
-
B. Alcala, C. Salcedo, L. Arreaza, R. Abad, R. Enriquez, and L. De La Fuente et al. Antigenic and/or phase variation of PorA protein in non-subtypable Neisseria meningitidis strains isolated in Spain J Med Microbiol 53 2004 515 518
-
(2004)
J Med Microbiol
, vol.53
, pp. 515-518
-
-
Alcala, B.1
Salcedo, C.2
Arreaza, L.3
Abad, R.4
Enriquez, R.5
De La Fuente, L.6
-
46
-
-
79957583774
-
A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease
-
E.L. Su, and M.D. Snape A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease Expert Rev Vaccines 10 2011 575 588
-
(2011)
Expert Rev Vaccines
, vol.10
, pp. 575-588
-
-
Su, E.L.1
Snape, M.D.2
-
47
-
-
63249115447
-
Delivering a safe and effective strain-specific vaccine to control an epidemic of group B meningococcal disease
-
J. O'Hallahan, A. McNicholas, Y. Galloway, E. O'Leary, and C. Roseveare Delivering a safe and effective strain-specific vaccine to control an epidemic of group B meningococcal disease N Z Med J 122 2009 48 59
-
(2009)
N Z Med J
, vol.122
, pp. 48-59
-
-
O'Hallahan, J.1
McNicholas, A.2
Galloway, Y.3
O'Leary, E.4
Roseveare, C.5
-
48
-
-
34247890242
-
Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005
-
P. Rouaud, A. Perrocheau, M.K. Taha, C. Sesboue, A.M. Forgues, and I. Parent du Chatelet et al. Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005 Euro Surveill 11 2006 178 181
-
(2006)
Euro Surveill
, vol.11
, pp. 178-181
-
-
Rouaud, P.1
Perrocheau, A.2
Taha, M.K.3
Sesboue, C.4
Forgues, A.M.5
Parent Du Chatelet, I.6
-
49
-
-
0026730501
-
Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil
-
J.C. De Moraes, B.A. Perkins, M.C. Camargo, N.T. Hidalgo, H.A. Barbosa, and C.T. Sacchi et al. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil Lancet 340 1992 1074 1078
-
(1992)
Lancet
, vol.340
, pp. 1074-1078
-
-
De Moraes, J.C.1
Perkins, B.A.2
Camargo, M.C.3
Hidalgo, N.T.4
Barbosa, H.A.5
Sacchi, C.T.6
-
50
-
-
77957941966
-
Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: A randomized comparative trial
-
M.D. Snape, T. Dawson, P. Oster, A. Evans, T.M. John, and B. Ohene-Kena et al. Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: A randomized comparative trial Pediatr Infect Dis J 29 2010 e71 e79
-
(2010)
Pediatr Infect Dis J
, vol.29
-
-
Snape, M.D.1
Dawson, T.2
Oster, P.3
Evans, A.4
John, T.M.5
Ohene-Kena, B.6
-
51
-
-
0028147943
-
Sero/subtyping of Neisseria meningitidis isolated from patients in Spain
-
J.A. Vazquez, C. Marcos, and S. Berron Sero/subtyping of Neisseria meningitidis isolated from patients in Spain Epidemiol Infect 113 1994 267 274
-
(1994)
Epidemiol Infect
, vol.113
, pp. 267-274
-
-
Vazquez, J.A.1
Marcos, C.2
Berron, S.3
-
53
-
-
84864147338
-
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: A randomised, single-blind, placebo-controlled, phase 2 trial
-
P.C. Richmond, H.S. Marshall, M.D. Nissen, Q. Jiang, K.U. Jansen, and M. Garces-Sanchez et al. Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: A randomised, single-blind, placebo-controlled, phase 2 trial Lancet Infect Dis 12 2012 597 607
-
(2012)
Lancet Infect Dis
, vol.12
, pp. 597-607
-
-
Richmond, P.C.1
Marshall, H.S.2
Nissen, M.D.3
Jiang, Q.4
Jansen, K.U.5
Garces-Sanchez, M.6
-
54
-
-
77955516093
-
Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
-
H.Q. Jiang, S.K. Hoiseth, S.L. Harris, L.K. McNeil, D. Zhu, and C. Tan et al. Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease Vaccine 28 2010 6086 6093
-
(2010)
Vaccine
, vol.28
, pp. 6086-6093
-
-
Jiang, H.Q.1
Hoiseth, S.K.2
Harris, S.L.3
McNeil, L.K.4
Zhu, D.5
Tan, C.6
-
55
-
-
4544303750
-
Biotechnology and vaccines: Application of functional genomics to Neisseria meningitidis and other bacterial pathogens
-
D. Serruto, J. Adu-Bobie, B. Capecchi, R. Rappuoli, M. Pizza, and V. Masignani Biotechnology and vaccines: Application of functional genomics to Neisseria meningitidis and other bacterial pathogens J Biotechnol 113 2004 15 32
-
(2004)
J Biotechnol
, vol.113
, pp. 15-32
-
-
Serruto, D.1
Adu-Bobie, J.2
Capecchi, B.3
Rappuoli, R.4
Pizza, M.5
Masignani, V.6
-
56
-
-
0035925596
-
Reverse vaccinology, a genome-based approach to vaccine development
-
R. Rappuoli Reverse vaccinology, a genome-based approach to vaccine development Vaccine 19 2001 2688 2691
-
(2001)
Vaccine
, vol.19
, pp. 2688-2691
-
-
Rappuoli, R.1
-
57
-
-
48249129970
-
Genome-based vaccine development: A short cut for the future
-
D.G. Moriel, M. Scarselli, L. Serino, M. Mora, R. Rappuoli, and V. Masignani Genome-based vaccine development: A short cut for the future Hum Vaccin 4 2008 184 188
-
(2008)
Hum Vaccin
, vol.4
, pp. 184-188
-
-
Moriel, D.G.1
Scarselli, M.2
Serino, L.3
Mora, M.4
Rappuoli, R.5
Masignani, V.6
-
58
-
-
0034629284
-
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing
-
M. Pizza, V. Scarlato, V. Masignani, M.M. Giuliani, B. Arico, and M. Comanducci et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing Science 287 2000 1816 1820
-
(2000)
Science
, vol.287
, pp. 1816-1820
-
-
Pizza, M.1
Scarlato, V.2
Masignani, V.3
Giuliani, M.M.4
Arico, B.5
Comanducci, M.6
-
59
-
-
84867397072
-
Developing vaccines in the era of genomics: A decade of reverse vaccinology
-
K.L. Seib, X. Zhao, and R. Rappuoli Developing vaccines in the era of genomics: A decade of reverse vaccinology Clin Microbiol Infect 18 Suppl 5 2012 109 116
-
(2012)
Clin Microbiol Infect
, vol.18
, Issue.SUPPL. 5
, pp. 109-116
-
-
Seib, K.L.1
Zhao, X.2
Rappuoli, R.3
-
60
-
-
33746593691
-
A universal vaccine for serogroup B meningococcus
-
M.M. Giuliani, J. Adu-Bobie, M. Comanducci, B. Arico, S. Savino, and L. Santini et al. A universal vaccine for serogroup B meningococcus Proc Natl Acad Sci U S A 103 2006 10834 10839
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 10834-10839
-
-
Giuliani, M.M.1
Adu-Bobie, J.2
Comanducci, M.3
Arico, B.4
Savino, S.5
Santini, L.6
-
61
-
-
79960790578
-
Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults
-
D. Toneatto, P. Oster, A.C. deBoer, A. Emerson, G.F. Santos, and E. Ypma et al. Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults Hum Vaccin 7 2011 781 791
-
(2011)
Hum Vaccin
, vol.7
, pp. 781-791
-
-
Toneatto, D.1
Oster, P.2
Deboer, A.C.3
Emerson, A.4
Santos, G.F.5
Ypma, E.6
-
62
-
-
14844296966
-
MeNZB: A safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain
-
P. Oster, D. Lennon, J. O'Hallahan, K. Mulholland, S. Reid, and D. Martin MeNZB: A safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain Vaccine 23 2005 2191 2196
-
(2005)
Vaccine
, vol.23
, pp. 2191-2196
-
-
Oster, P.1
Lennon, D.2
O'Hallahan, J.3
Mulholland, K.4
Reid, S.5
Martin, D.6
-
63
-
-
78349257850
-
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy
-
J. Findlow, R. Borrow, M.D. Snape, T. Dawson, A. Holland, and T.M. John et al. Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy Clin Infect Dis 51 2010 1127 1137
-
(2010)
Clin Infect Dis
, vol.51
, pp. 1127-1137
-
-
Findlow, J.1
Borrow, R.2
Snape, M.D.3
Dawson, T.4
Holland, A.5
John, T.M.6
-
64
-
-
84897452749
-
Bactericidal antibody persistence two years following meningococcal B vaccination at 6, 8, and 12 months in 40-month old children
-
Thessaloniki, Greece. 8-11 Poster No 653. Disponible en
-
J. Philip, M.D. Snape, H. Robinson, S. Kelly, A.J. Pollard, and T.M. John et al. Bactericidal antibody persistence two years following meningococcal B vaccination at 6, 8, and 12 months in 40-month old children Poster presented at the European Society for Paediatric Infectious Diseases (ESPID) annual meeting Thessaloniki, Greece. 8-11 2012 Poster No 653. Disponible en: www.kenes.com/espid2012/abstracts/
-
(2012)
Poster Presented at the European Society for Paediatric Infectious Diseases (ESPID) Annual Meeting
-
-
Philip, J.1
Snape, M.D.2
Robinson, H.3
Kelly, S.4
Pollard, A.J.5
John, T.M.6
-
65
-
-
84897454266
-
Persistence of bactericidal antibodies following early infant immunisation with serogroup B meningococcal vaccines and immunogenicity of pre-school booster doses - A follow-on study
-
Thessaloniki, Greece. 8-11 Poster No 664. Disponible en
-
P. Saroey, M.D. Snape, T.M. John, H. Robinson, S. Kelly, and N. Gossger et al. Persistence of bactericidal antibodies following early infant immunisation with serogroup B meningococcal vaccines and immunogenicity of pre-school booster doses - a follow-on study Poster presented at the European Society for Paediatric Infectious Diseases (ESPID) annual meeting Thessaloniki, Greece. 8-11 2012 Poster No 664. Disponible en: www.kenes.com/espid2012/ abstracts/
-
(2012)
Poster Presented at the European Society for Paediatric Infectious Diseases (ESPID) Annual Meeting
-
-
Saroey, P.1
Snape, M.D.2
John, T.M.3
Robinson, H.4
Kelly, S.5
Gossger, N.6
-
66
-
-
84856773073
-
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: A randomized controlled trial
-
N. Gossger, M.D. Snape, L.M. Yu, A. Finn, G. Bona, and S. Esposito et al. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: A randomized controlled trial JAMA 307 2012 573 582
-
(2012)
JAMA
, vol.307
, pp. 573-582
-
-
Gossger, N.1
Snape, M.D.2
Yu, L.M.3
Finn, A.4
Bona, G.5
Esposito, S.6
-
67
-
-
79957593818
-
Immunogenicity of an investigational, multicomponent, meningococcall serogroup B vaccine in healthy infants at 2, 4, and 6 months of age
-
Banff, Canada, Sept 11-16 Poster No 180. Disponibleen
-
T. Vesikari, S. Esposito, A. Kimura, A. Kleinschmidt, E. Ypma, and D. Toneatto et al. Immunogenicity of an investigational, multicomponent, meningococcall serogroup B vaccine in healthy infants at 2, 4, and 6 months of age Presented at: International Pathogenic Neisseria Conference Banff, Canada, Sept 11-16 2010 Poster No 180. Disponible en: http://neisseria.org/ipnc/2010/ IPNC-2010
-
(2010)
Presented At: International Pathogenic Neisseria Conference
-
-
Vesikari, T.1
Esposito, S.2
Kimura, A.3
Kleinschmidt, A.4
Ypma, E.5
Toneatto, D.6
-
68
-
-
84855585556
-
Tolerability of a three-dose schedule of an investigational, multicomponent, meningococcal serogroup B vaccine and routine infant vaccines in a lot consistency trial
-
Banff, Canada, Sept 11-16 Poster No 182. Disponible en
-
S. Esposito, T. Vesikari, A. Kimura, E. Ypma, D. Toneatto, and P. Dull Tolerability of a three-dose schedule of an investigational, multicomponent, meningococcal serogroup B vaccine and routine infant vaccines in a lot consistency trial Presented at International Pathogenic Neisseria Conference Banff, Canada, Sept 11-16 2010 Poster No 182. Disponible en: http://neisseria.org/ipnc/2010/IPNC-2010
-
(2010)
Presented at International Pathogenic Neisseria Conference
-
-
Esposito, S.1
Vesikari, T.2
Kimura, A.3
Ypma, E.4
Toneatto, D.5
Dull, P.6
-
69
-
-
84897436490
-
Catch-up vaccination of healthy toddlers with an investigational multicomponent meningococcal serogroup b vaccine (4 cmenb) - Exploration of a two-dose schedule
-
The Hague, The Netherlands, June 7-11 Poster No 706. Disponible en
-
R. Prymula, T. Vesikari, T. Esposito, I. Kohl, E. Ypma, and D. Toneatto et al. Catch-up vaccination of healthy toddlers with an investigational multicomponent meningococcal serogroup b vaccine (4 cmenb) - exploration of a two-dose schedule Present at 29th ESPID Meeting The Hague, The Netherlands, June 7-11 2011 Poster No 706. Disponible en: www.kenes.com/espid2011/cd/
-
(2011)
Present at 29th ESPID Meeting
-
-
Prymula, R.1
Vesikari, T.2
Esposito, T.3
Kohl, I.4
Ypma, E.5
Toneatto, D.6
-
70
-
-
84857238470
-
Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4 CMenB) vaccine in healthy adolescents in Chile: A phase 2b/3 randomised, observer-blind, placebo-controlled study
-
M.E. Santolaya, M.L. O'Ryan, M.T. Valenzuela, V. Prado, R. Vergara, and A. Munoz et al. Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4 CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study Lancet 379 2012 617 624
-
(2012)
Lancet
, vol.379
, pp. 617-624
-
-
Santolaya, M.E.1
O'Ryan, M.L.2
Valenzuela, M.T.3
Prado, V.4
Vergara, R.5
Munoz, A.6
-
71
-
-
78650604587
-
Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines
-
J. Donnelly, D. Medini, G. Boccadifuoco, A. Biolchi, J. Ward, and C. Frasch et al. Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines Proc Natl Acad Sci U S A 107 2010 19490 19495
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 19490-19495
-
-
Donnelly, J.1
Medini, D.2
Boccadifuoco, G.3
Biolchi, A.4
Ward, J.5
Frasch, C.6
-
72
-
-
84867281306
-
Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines
-
B.D. Plikaytis, M. Stella, G. Boccadifuoco, L.M. Detora, M. Agnusdei, and L. Santini et al. Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines Clin Vaccine Immunol 19 2012 1609 1617
-
(2012)
Clin Vaccine Immunol
, vol.19
, pp. 1609-1617
-
-
Plikaytis, B.D.1
Stella, M.2
Boccadifuoco, G.3
Detora, L.M.4
Agnusdei, M.5
Santini, L.6
-
73
-
-
84874684040
-
Estimating the potential strain coverage in europe of a multicomponent vaccine targeting serogroup b meningococci
-
Ljubljana, Slovenia, 18-20 May Disponible en
-
J. Donnelly, D. Medini, G. Boccadifuoco, A. Biolchi, J. Ward, and C. Frasch et al. Estimating the potential strain coverage in europe of a multicomponent vaccine targeting serogroup b meningococci Oral communication presented at: 11th meeting of The European Meningococcal Disease Society (EMGM) Ljubljana, Slovenia, 18-20 May 2011 Disponible en: http://emgm.eu/meetings/ emgm2011/abstracts.pdf
-
(2011)
Oral Communication Presented At: 11th Meeting of the European Meningococcal Disease Society (EMGM)
-
-
Donnelly, J.1
Medini, D.2
Boccadifuoco, G.3
Biolchi, A.4
Ward, J.5
Frasch, C.6
-
74
-
-
84930720121
-
Strain coverage of a meningococcal multicomponent (4 CMenB) vaccine in Spain
-
Würzburg, Alemania Disponible en
-
R. Abad, L. Orlandi, F. Rigat, G. Boccadifuoco, M. Comanducci, and A. Muzzi et al. Strain coverage of a meningococcal multicomponent (4 CMenB) vaccine in Spain XVIII International Pathogenic Neisseria Conference Würzburg, Alemania 2012 Disponible en: http://www.conventus.de/index.php?id=ipnc2012- abstracts
-
(2012)
XVIII International Pathogenic Neisseria Conference
-
-
Abad, R.1
Orlandi, L.2
Rigat, F.3
Boccadifuoco, G.4
Comanducci, M.5
Muzzi, A.6
|